Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price target increased by equities researchers at TD Securities from C$53.00 to C$54.00 in a research note issued on Thursday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ target price points to a potential upside of 21.18% from the stock’s current price.
A number of other brokerages have also recently issued reports on AND. Royal Bank of Canada increased their target price on Andlauer Healthcare Group from C$41.00 to C$42.00 and gave the stock a “sector perform” rating in a report on Friday, August 2nd. Eight Capital lowered their price objective on shares of Andlauer Healthcare Group from C$58.00 to C$51.00 and set a “buy” rating on the stock in a report on Friday, August 2nd. Finally, Scotiabank reduced their price objective on shares of Andlauer Healthcare Group to C$43.00 in a report on Thursday, October 10th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of C$48.57.
Check Out Our Latest Stock Analysis on Andlauer Healthcare Group
Andlauer Healthcare Group Stock Up 1.7 %
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Read More
- Five stocks we like better than Andlauer Healthcare Group
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Best Stocks Under $5.00
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.